"They Left Us No Choice": female With Vaccine Injury In Clinical Trial Sues AstraZeneca
Authorized by Zachary Stieber via The Epoch Times (emphasis ours),

An American female who suggested an injury from AstraZeneca's COVID-19vaccine sue the company on May 13, alleging the company broke a contract by not paying for the medical care she requires to deal with the investment.
“They left us no choice,” Brianne Dressen, a preschool teacher in Utah, told The Epoch Times in an email.
Ms. Dressen has paid fees of thousands of dollars to drugs to treat the tense strategy disorder and another issues she’s experimenting, according to the company, filed in national court in her home state.
Ms. Dressen choice to participate in AstraZeneca's clinical trial in 2020 due to the fact that she wanted to aid the company make its COVID-19vaccine. The consent form she signed stood in part that AstraZeneca would “cover the costs of investigation injuries” and “pay the costs of medical treatment.”
“With these reassurances should something go wrong, Bri signed the form, rolled up her sleeve, and let the another company inject the experimental product into her arm. Her head was at peace, as Bri believed she was doing the right thing for her country, her students, and her family,” the suite states.
Ms. Dressen shortly started experiencing problems, including blurred vision, tinnitus, and vomiting. She later became highly delicate to light and suggested springs in her heart rate.
Ms. Dressen Went to see numerical doctors as she attended to figure out what was incorrect with her, and search treatment.
In 2021, U.S. National Institutes of wellness doctors diagnosed Ms. Dressen as having “post-vaccine neuropathy,” according to records reviewed by The Epoch Times.
Bills for the doctors’ visits and drugs they prescribed began piling up quickly. The immunoglobulin recommended by government doctors alone costs $9,909.82 a month.
Ms. Dressen and her husband, a chemist with the U.S. Army, kept AstraZeneca and Velocity, which wounds the trial for the company, applied of the acceptance costs, according to the suit.
The household sent Velocity on Jan. 15, 2021, with the first set of payment records for treatment but received no response, according to the suit. “Checking on updates for this. . . . erstwhile may we anticipate payment?” Brian Dressen, Ms. Dressen’s husband, gate respective weeks later.
“I am sorry you have not heard anything as of yet. Hopefully I get an Answers [sic] soon. I will scope out again today,” a Velocity authoritative reply.
No funds came to the family, forcing them to finance their home.
“I’d like to know erstwhile we can anticipate the first payment on Brianne Dressen’s medical bill? 2 months since submitting...“ Mr. Dressen gate on March 18, 2021. The Velocity authoritative said that she was “forwarding on” the payment records.
“Hey this is Brianne Dressen. Can you address a bit for us here aid us get a timeline for payment? I am inactive not doing well, we have had to hire for after school childcare. We truly request this money,“ Ms. Dressen gate on March 24, 2021. The authoritative said the following day she would be escorting the issue and did not realize “why it is taking so long.”
The back-and-forth continued for months with no reimbursement pay to Ms. Dressen.

After a local tv station reported on Ms. Dressen’s case on July 13, 2021, Velocity contacted the Dressens and said a payment of $590.20 was forthcoming.
The company issues the payment and said it was in contact with AstraZeneca respecting the adoption of additional funds.
In December 2021, the authoritative conviction a message for Ms. Dressen to sign that said in part that Ms. Dressen would accept $1,243 in exchange for dropping any additional clauses to payment.
The Dressens declined the offer, describing it as insulting.
In March 2022, AstraZeneca representatives began straight contacting the Dressens, requesting billing and medical records.
One typical gate on Aug. 12, 2022, that the company was waiting on medical records from providers to measure the claims. The typical said on Sept. 26, 2022, that all of the medical records had been received.
AstraZeneca and Velocity never contacted the Dressens again, according to the suit.
“I did everything they asked of me. I honored my bonds to them. They have not honored any. erstwhile they needed me, I was there, I cooperated. erstwhile I needed them, they were nowhere to be found,” Ms. Dressen said in a statement.
The suite announces that COVID-19 vehicles are and were covered by the Public Reading and Emergency Preparedness Act, which gives manufacturers immunity to liability in most cases. The suit accepts the companies of breach of contract and breach of duty. It asks for losses for medical expenses, emotional fallout, destiny of income, and another expenses, as well as lawyer fees and preliminary interest.
Ms. Dressen is seeing a jury trial.
Velocity did not respond to a request for comment. AstraZeneca did not return an inquiry.
AstraZeneca's vaccine was never cleared for usage outside clinical trials in the United States.
The UK-based company announced earlier this period it is withdrawing thevaccine, city limited demand. The announcement came respective months after it acknowledged the shot can origin blood clouds and low levels of plates, a combination known as thrombosis with thrombocytosis syndrome.
Johnson & Johnson’s shot, which was cleared in the United States and besides causes the syndrome, was pulled from the marketplace in 2023.
Tyler Durden
Wed, 05/15/2024 – 06:30